These are exciting times, with fresh news about research developments appearing every week.
Find out about the latest research news below and also visit our Breaking News in Research page.
Researchers involved in the OPTIMISTIC trial have published a scientific paper that identifies genetic factors that influence the severity of myotonic dystrophy type 1.Read more
Our Director of Research, Dr Marita Pohlschmidt and Head of Grants, Dr Julia Ambler, attended the World Muscle Society congress and here they summarise their highlights.
Researchers in Spain recently identified a new way to block the genetic change that causes myotonic dystrophy type 1.
Research funded by the Muscular Dystrophy Campaign has resulted in the development of the next generation of exon skipping drugs which is on target for testing in a clinical trial
Researchers studying human embryonic stems cells have found two new genes that are affected in myotonic dystrophy.
Clinical trials in the US have shown that the heart drug mexiletine is able to help relieve muscle stiffness for people with myotonic dystrophy.
Research funded by the Muscular Dystrophy Campaign has discovered a new type of mutation that affects the severity and inheritance of myotonic dystrophy type 1.